Postmarketing experience with Neutrolin® (taurolidine, heparin, calcium citrate) catheter lock solution in hemodialysis patients

Overview of attention for article published in European Journal of Clinical Microbiology & Infectious Diseases, December 2017

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (92nd percentile)
High Attention Score compared to outputs of the same age and source (88th percentile)

Mentioned by

news: 2 news outlets
twitter: 7 X users

patent: 2 patents

Readers on

mendeley: 38 Mendeley

Summary News X Patents

So far, Altmetric has seen 2 patents that reference this research output.

Neuroblastoma treatment with taurolidine hydrolysis products

Grant US-11541061-B2

United States of America

NEUROBLASTOMA TREATMENT WITH TAUROLIDINE HYDROLYSIS PRODUCTS

Application WO-2020047113-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.